Louisiana State Employees Retirement System’s Pacira BioSciences PCRX Stock Holding History

Louisiana State Employees Retirement System’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$436K	Sell	17,200 -1,000	-5%	-$23.6K	0.01%	1433
2026 Q1	$411K	Sell	18,200 -1,500	-8%	-$33.3K	0.01%	1404
2025 Q4	$510K	Sell	19,700 -1,000	-5%	-$23.8K	0.01%	1352
2025 Q3	$533K	Sell	20,700 -900	-4%	-$22.1K	0.01%	1316
2025 Q2	$516K	Sell	21,600 -100	-0.5%	-$2.52K	0.01%	1305
2025 Q1	$539K	Sell	21,700 -600	-3%	-$14.4K	0.01%	1294
2024 Q4	$420K	Hold	22,300	–	–	0.01%	1399
2024 Q3	$336K	Sell	22,300 -1,100	-5%	-$18.8K	0.01%	1466
2024 Q2	$669K	Buy	23,400 +400	+2%	+$11.4K	0.01%	1217
2024 Q1	$672K	Sell	23,000 -200	-0.9%	-$6.14K	0.01%	1221
2023 Q4	$783K	Sell	23,200 -400	-2%	-$11.7K	0.02%	1143
2023 Q3	$724K	Sell	23,600 -500	-2%	-$18K	0.02%	1103
2023 Q2	$966K	Buy	24,100 +2,700	+13%	+$112K	0.02%	921
2023 Q1	$873K	Sell	21,400 -400	-2%	-$15.9K	0.02%	908
2022 Q4	$842K	Sell	21,800 -100	-0.5%	-$4.87K	0.02%	901
2022 Q3	$1.17M	Sell	21,900 -100	-0.5%	-$5.56K	0.03%	618
2022 Q2	$1.19M	Buy	22,000 +300	+1%	+$19.7K	0.03%	658
2022 Q1	$1.63M	Buy	21,700 +100	+0.5%	+$6.67K	0.04%	514
2021 Q4	$1.3M	Buy	21,600 +200	+0.9%	+$11K	0.03%	721
2021 Q3	$1.2M	Buy	21,400 +1,500	+8%	+$86.5K	0.03%	745
2021 Q2	$1.21M	Hold	19,900	–	–	0.03%	729
2021 Q1	$1.4M	Sell	19,900 -100	-0.5%	-$7.14K	0.04%	569
2020 Q4	$1.2M	Buy	20,000 +200	+1%	+$11.7K	0.03%	585
2020 Q3	$1.19M	Buy	19,800 +8,380	+73%	+$487K	0.05%	406
2020 Q2	$599K	Sell	11,420 -100	-0.9%	-$4.18K	0.04%	667
2020 Q1	$386K	Sell	11,520 -2,770	-19%	-$115K	0.03%	788
2019 Q4	$647K	Buy	+14,290	New	+$607K	0.03%	819

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Louisiana State Employees Retirement System's PCRX Position: Q2 2026 in Review

Louisiana State Employees Retirement System reduced its Pacira BioSciences (PCRX) stake by 5.5% in Q2 2026, selling an estimated $23.6K and leaving 17,200 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #1433.

Louisiana State Employees Retirement System first reported a position in PCRX in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.63M in Q1 2022. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Louisiana State Employees Retirement System held 17,200 shares of Pacira BioSciences worth $436K as of Q2 2026.
Louisiana State Employees Retirement System sold 1,000 Pacira BioSciences shares in Q2 2026, an estimated $23.6K.
Pacira BioSciences made up 0.01% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #1433 holding.
Louisiana State Employees Retirement System first reported a position in Pacira BioSciences in Q4 2019 and has held it in 27 quarters since.
Louisiana State Employees Retirement System's Pacira BioSciences position peaked at $1.63M in Q1 2022.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.